Document Detail


Modification of sample size in group sequential clinical trials.
MedLine Citation:
PMID:  11315017     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In group sequential clinical trials, sample size reestimation can be a complicated issue when it allows for change of sample size to be influenced by an observed sample path. Our simulation studies show that increasing sample size based on an interim estimate of the treatment difference can substantially inflate the probability of type I error in most practical situations. A new group sequential test procedure is developed by modifying the weights used in the traditional repeated significance two-sample mean test. The new test has the type I error probability preserved at the target level and can provide a substantial gain in power with the increase of sample size. Generalization of the new procedure is discussed.
Authors:
L Cui; H M Hung; S J Wang
Related Documents :
17365227 - An alternative approach to assess exchangeability of a test treatment and the standard ...
25167827 - Improved short-term toxicity test protocol to assess metal tolerance in phototrophic pe...
9880997 - Goodness-of-fit tests for the additive risk model with (p > 2)-dimensional time-invaria...
7766777 - Step-up multiple testing of parameters with unequally correlated estimates.
17972537 - Diagnostic yield of adenosine and nitroglycerine stimulated tilt test in patients with ...
15599647 - Diagnosis of legionella infection in legionnaires' disease.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Biometrics     Volume:  55     ISSN:  0006-341X     ISO Abbreviation:  Biometrics     Publication Date:  1999 Sep 
Date Detail:
Created Date:  2001-04-20     Completed Date:  2001-08-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370625     Medline TA:  Biometrics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  853-7     Citation Subset:  IM    
Affiliation:
Division of Biometrics I, OB/CDER, Food and Drug Administration, Rockville, Maryland 20852, USA. cuil@cder.fda.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biometry*
Clinical Trials as Topic / statistics & numerical data*
Humans
Probability
Sample Size
Grant Support
ID/Acronym/Agency:
RSR-096-010A/RS/DRS NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Statistical quality control of variety trial data.
Next Document:  A Bayesian hierarchical approach for combining case-control and prospective studies.